• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

迟发性鸟氨酸转氨甲酰酶缺乏症的肝移植:一例报告。

Liver transplantation for late-onset ornithine transcarbamylase deficiency: A case report.

作者信息

Fu Xiao-Hui, Hu Yu-Hui, Liao Jian-Xiang, Chen Li, Hu Zhan-Qi, Wen Jia-Lun, Chen Shu-Li

机构信息

Department of Inherited Metabolic Disorders, The Affiliated Hospital of China Medical University and Shenzhen Children's Hospital, Shenzhen 518038, Guangdong Province, China.

Department of Neurology, The Affiliated Hospital of China Medical University and Shenzhen Children's Hospital, Shenzhen 518038, Guangdong Province, China.

出版信息

World J Clin Cases. 2022 Jun 26;10(18):6156-6162. doi: 10.12998/wjcc.v10.i18.6156.

DOI:10.12998/wjcc.v10.i18.6156
PMID:35949846
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC9254178/
Abstract

BACKGROUND

Ornithine transcarbamylase deficiency (OTCD) is an X-linked inherited disorder and characterized by marked elevation of blood ammonia. The goal of treatment is to minimize the neurological damage caused by hyperammonemia. OTCD can be cured by liver transplantation (LT). Post-transplant patients can discontinue anti- hyperammonemia agents and consume a regular diet without the risk of developing hyperammonemia. The neurological damage caused by hyperammonemia is almost irreversible.

CASE SUMMARY

An 11.7-year-old boy presented with headache, vomiting, and altered consciousness. The patient was diagnosed with late-onset OTCD. After nitrogen scavenging treatment and a protein-free diet, ammonia levels were reduced to normal on the third day of admission. Nevertheless, the patient remained in a moderate coma. After discussion, LT was performed. Following LT, the patient's blood ammonia and biochemical indicators stabilized in the normal range, he regained consciousness, and his nervous system function significantly recovered. Two months after LT, blood amino acids and urine organic acids were normal, and brain magnetic resonance imaging showed a decrease in subcortical lesions.

CONCLUSION

LT can significantly improve partial neurological impairment caused by late-onset OTCD hyperammonemic encephalopathy, and LT can be actively considered when early drug therapy is ineffective.

摘要

背景

鸟氨酸转氨甲酰酶缺乏症(OTCD)是一种X连锁遗传性疾病,其特征为血氨显著升高。治疗的目标是将高氨血症所致的神经损伤降至最低。OTCD可通过肝移植(LT)治愈。移植后患者可停用抗高氨血症药物并正常饮食,而不会有发生高氨血症的风险。高氨血症所致的神经损伤几乎不可逆转。

病例摘要

一名11.7岁男孩出现头痛、呕吐及意识改变。该患者被诊断为迟发性OTCD。经过排氮治疗及无蛋白饮食,入院第三天血氨水平降至正常。然而,患者仍处于中度昏迷状态。经讨论后,实施了肝移植。肝移植后,患者的血氨及生化指标稳定在正常范围,意识恢复,神经系统功能明显恢复。肝移植后两个月,血氨基酸及尿有机酸正常,脑磁共振成像显示皮质下病变减少。

结论

肝移植可显著改善迟发性OTCD高氨血症性脑病所致的部分神经功能损害,早期药物治疗无效时可积极考虑肝移植。

https://cdn.ncbi.nlm.nih.gov/pmc/blobs/5ded/9254178/5f665127597c/WJCC-10-6156-g002.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/5ded/9254178/a3536185216b/WJCC-10-6156-g001.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/5ded/9254178/5f665127597c/WJCC-10-6156-g002.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/5ded/9254178/a3536185216b/WJCC-10-6156-g001.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/5ded/9254178/5f665127597c/WJCC-10-6156-g002.jpg

相似文献

1
Liver transplantation for late-onset ornithine transcarbamylase deficiency: A case report.迟发性鸟氨酸转氨甲酰酶缺乏症的肝移植:一例报告。
World J Clin Cases. 2022 Jun 26;10(18):6156-6162. doi: 10.12998/wjcc.v10.i18.6156.
2
Liver transplantation in rare late-onset ornithine transcarbamylase deficiency with central nervous system injury: A case report and review of the literature.罕见迟发性鸟氨酸转氨甲酰酶缺乏伴中枢神经系统损伤的肝移植:病例报告及文献复习。
Brain Behav. 2022 Oct;12(10):e2765. doi: 10.1002/brb3.2765. Epub 2022 Sep 20.
3
Late-Onset Ornithine Transcarbamylase Deficiency Complicated with Extremely High Serum Ammonia Level: Prompt Induction of Hemodialysis as the Key to Successful Treatment.迟发性鸟氨酸氨甲酰基转移酶缺陷症伴极高血清氨水平:及时诱导血液透析是成功治疗的关键。
Am J Case Rep. 2022 Nov 15;23:e937658. doi: 10.12659/AJCR.937658.
4
Liver transplantation in ornithine transcarbamylase deficiency: A retrospective multicentre cohort study.鸟氨酸转氨甲酰酶缺乏症的肝移植:一项回顾性多中心队列研究。
Mol Genet Metab Rep. 2023 Nov 5;37:101020. doi: 10.1016/j.ymgmr.2023.101020. eCollection 2023 Dec.
5
Complete recovery from acute encephalopathy of late-onset ornithine transcarbamylase deficiency in a 3-year-old boy.一名3岁男孩晚发型鸟氨酸转氨甲酰酶缺乏症所致急性脑病完全康复。
J Inherit Metab Dis. 2007 Nov;30(6):981. doi: 10.1007/s10545-007-0692-x. Epub 2007 Oct 5.
6
[Consensus on diagnosis and treatment of ornithine trans-carbamylase deficiency].鸟氨酸转氨甲酰酶缺乏症诊断与治疗共识
Zhejiang Da Xue Xue Bao Yi Xue Ban. 2020 Oct 25;49(5):539-547. doi: 10.3785/j.issn.1008-9292.2020.04.11.
7
Late-onset of ornithine transcarbamylase deficiency: A rare medical examiner case.鸟氨酸转氨甲酰酶缺乏症的迟发性:一例罕见的法医案例。
J Forensic Sci. 2022 Mar;67(2):813-819. doi: 10.1111/1556-4029.14934. Epub 2021 Nov 2.
8
Antepartum ornithine transcarbamylase deficiency.产前鸟氨酸转氨甲酰酶缺乏症。
Case Rep Gastroenterol. 2014 Nov 5;8(3):337-45. doi: 10.1159/000369131. eCollection 2014 Sep-Dec.
9
Case Report: Juvenile Myelomonocytic Leukemia Underlying Ornithine Transcarbamylase Deficiency Safely Treated Using Hematopoietic Stem Cell Transplantation.病例报告:鸟氨酸转氨甲酰酶缺乏症基础上的青少年骨髓单核细胞白血病经造血干细胞移植安全治愈
Front Pediatr. 2022 May 6;10:898531. doi: 10.3389/fped.2022.898531. eCollection 2022.
10
Prenatal treatment of ornithine transcarbamylase deficiency.鸟氨酸氨甲酰基转移酶缺陷症的产前治疗。
Mol Genet Metab. 2018 Mar;123(3):297-300. doi: 10.1016/j.ymgme.2018.01.004. Epub 2018 Jan 16.

引用本文的文献

1
In-depth analysis of A208T case induced by gene mutation and research on the prediction and simulation of the impact on protein function.基因突变诱导的A208T病例深入分析及对蛋白质功能影响的预测与模拟研究
Front Pediatr. 2024 Sep 12;12:1450859. doi: 10.3389/fped.2024.1450859. eCollection 2024.

本文引用的文献

1
[Consensus on diagnosis and treatment of ornithine trans-carbamylase deficiency].鸟氨酸转氨甲酰酶缺乏症诊断与治疗共识
Zhejiang Da Xue Xue Bao Yi Xue Ban. 2020 Oct 25;49(5):539-547. doi: 10.3785/j.issn.1008-9292.2020.04.11.
2
Liver and/or kidney transplantation in amino and organic acid-related inborn errors of metabolism: An overview on European data.肝/肾移植治疗氨基酸和有机酸代谢相关先天性遗传代谢病:欧洲数据综述。
J Inherit Metab Dis. 2021 May;44(3):593-605. doi: 10.1002/jimd.12318. Epub 2020 Oct 29.
3
Suggested guidelines for the diagnosis and management of urea cycle disorders: First revision.
尿素循环障碍的诊断和管理建议指南:第一版修订。
J Inherit Metab Dis. 2019 Nov;42(6):1192-1230. doi: 10.1002/jimd.12100. Epub 2019 May 15.
4
Early liver transplantation in neonatal-onset and moderate urea cycle disorders may lead to normal neurodevelopment.新生儿期和中度尿素循环障碍的早期肝移植可能导致正常的神经发育。
Metab Brain Dis. 2018 Oct;33(5):1517-1523. doi: 10.1007/s11011-018-0259-6. Epub 2018 Jun 11.
5
Long-term outcomes in Ornithine Transcarbamylase deficiency: a series of 90 patients.鸟氨酸转氨甲酰酶缺乏症的长期预后:90例患者的系列研究
Orphanet J Rare Dis. 2015 May 10;10:58. doi: 10.1186/s13023-015-0266-1.
6
Urea cycle disorders: a case report of a successful treatment with liver transplant and a literature review.尿素循环障碍:一例肝移植成功治疗的病例报告及文献综述
World J Gastroenterol. 2015 Apr 7;21(13):4063-8. doi: 10.3748/wjg.v21.i13.4063.
7
Living donor liver transplantation for pediatric patients with metabolic disorders: the Japanese multicenter registry.日本多中心登记处:小儿代谢紊乱患者的活体供肝肝移植
Pediatr Transplant. 2014 Feb;18(1):6-15. doi: 10.1111/petr.12196. Epub 2013 Nov 28.
8
The incidence of urea cycle disorders.尿素循环障碍的发病率。
Mol Genet Metab. 2013 Sep-Oct;110(1-2):179-80. doi: 10.1016/j.ymgme.2013.07.008. Epub 2013 Jul 18.
9
Impact of enzyme activity assay on indication in liver transplantation for ornithine transcarbamylase deficiency.鸟氨酸氨甲酰基转移酶缺陷症肝移植中酶活性测定对适应证的影响。
Mol Genet Metab. 2012 Mar;105(3):404-7. doi: 10.1016/j.ymgme.2011.12.019. Epub 2012 Jan 4.
10
Long-term outcome and intervention of urea cycle disorders in Japan.日本尿素循环障碍的长期预后和干预措施。
J Inherit Metab Dis. 2012 Sep;35(5):777-85. doi: 10.1007/s10545-011-9427-0. Epub 2011 Dec 14.